Development of Zr-89-Ontuxizumab for in vivo TEM-1/endosialin PET applications

Authors

Sara E. S. Lange, Washington University School of Medicine
Alex Zheleznyak, Washington University School of Medicine
Matthew Studer, Washington University School of Medicine
Daniel J. O'Shannessy, Morphotex Inc.
Suzanne E. Lapi, Washington University School of Medicine
Brian A. Van Tine, Washington University School of Medicine

Journal

Oncotarget

Publication Date

2016

Volume

7

Issue

11

Inclusive Pages

13082-13092

Document Type

Open Access Publication

Rights and Permissions

Lange, S. E. S., Zheleznyak, A., Studer, M., O'Shannessy, D. J., Lapi, S. E., & Van Tine, B. A. (2016). Development of 89Zr-ontuxizumab for in vivo TEM-1/endosialin PET applications. Oncotarget, 7(11), 13082-13092. Copyright: © Lange et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Lange, Sara E. S.; Zheleznyak, Alex; Studer, Matthew; O'Shannessy, Daniel J.; Lapi, Suzanne E.; and Van Tine, Brian A., "Development of Zr-89-Ontuxizumab for in vivo TEM-1/endosialin PET applications." Oncotarget. 7, 11. 13082-13092. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5009